The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now ...

Swiss medical regulators have approved a new malaria treatment for infants, offering hope to many in Africa KAMPALA, Uganda - ...

The patient has not traveled outside of the U.S., so officials are looking into how he could have acquired the mosquito-borne ...

Ugandan trial shows reduced efficacy of artemether-lumefantrine for malaria, with resistance mutations causing higher ...

Nigeria has been named among eight African countries that contributed to a clinical trial leading to the approval of the ...

The approval of Coartem Baby by Swiss regulators marks a breakthrough in malaria treatment for infants. This drug, tailored for babies weighing 2-5 kg, could significantly reduce malaria-related ...

The first malaria treatment suitable for babies and very young children has been approved for use. It's expected to be rolled out in African countries within weeks. Until now there have been no ...

New infant-friendly formulation closes a critical treatment gap for the youngest children, with support from African-led ...

If confirmed, it would be the first case of locally acquired malaria in New Jersey since 1991. There are about 100 ...

Young boy brought to ER at Sheba Medical Center with a high fever was diagnosed with malaria, which he contracted during a ...

The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now ...